| Market Capitalization (Millions $) |
347 |
| Shares
Outstanding (Millions) |
95 |
| Employees |
2,700 |
| Revenues (TTM) (Millions $) |
806 |
| Net Income (TTM) (Millions $) |
-113 |
| Cash Flow (TTM) (Millions $) |
42 |
| Capital Exp. (TTM) (Millions $) |
22 |
Business Description
Myriad Genetics Inc.
is a leading biotechnology company in the United States that specifically focuses on the development and commercialization of molecular diagnostic tests.
The company is based in Salt Lake City, Utah and was founded in 1991.
Myriad Genetics is widely recognized for its innovative diagnostic tests, which help assess the risk of developing certain diseases, including inherited cancers, cardiovascular diseases, neurological disorders, and other genetic conditions.
The company has developed several proprietary technologies that enable its diagnostic tests to provide highly accurate and reliable results.
Myriad Genetics' most well-known product is its BRACAnalysis test, which is used to identify mutations in the BRCA1 and BRCA2 genes.
These mutations have been linked to breast and ovarian cancer, and the BRACAnalysis test is a key tool in helping healthcare professionals assess patients' risk of developing these diseases.
Myriad Genetics has also developed a range of other diagnostic tests, including its myRisk Hereditary Cancer test, which assesses the risk of developing several hereditary cancers using a multi-gene panel.
The company has also expanded into the field of companion diagnostics, working with pharmaceutical companies to develop tests that can identify patients who are likely to respond to specific treatments.
In addition to its diagnostic products, Myriad Genetics also operates a research and development division, which is dedicated to discovering new diagnostic and therapeutic technologies.
Myriad Genetics has received numerous awards and honors for its innovative work, including being named one of the world's most innovative companies by Forbes magazine.
As of 2021, Myriad Genetics has over 2,600 employees worldwide and its products are used in over 100 countries.
The company remains committed to advancing genetic testing and personalized medicine, with a focus on providing patients and healthcare professionals with the most accurate and reliable diagnostic information possible.
Company Address: 322 North 2200 West Salt Lake City 84116 UT
Company Phone Number: 584-3600 Stock Exchange / Ticker: NASDAQ MYGN
|
7.14% 
122.86 %